Literature DB >> 8486059

Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis.

B Imbeault1, Y Cormier.   

Abstract

Two patients with allergic bronchopulmonary aspergillosis were seen on a regular basis, one since 1978 and the other since 1982. Throughout this period, both subjects required daily oral administration of corticosteroids (between 15 and 40 mg of prednisolone daily) to control their symptoms and the lung infiltrates on the chest x-ray film. Attempts to further decrease the dosage of steroids or to discontinue their use were met with immediate recurrences of manifestations of the disease. With the introduction of high-dose inhaled beclomethasone dipropionate, both subjects could be weaned from their oral steroids and maintained with inhaled steroids alone for up to 11 months. We conclude that inhaled corticosteroids may be useful in the treatment of allergic bronchopulmonary aspergillosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486059     DOI: 10.1378/chest.103.5.1614

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

Review 2.  Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Authors:  Ibrahim Ahmed Janahi; Abdul Rehman; Amal Rashid Al-Naimi
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

3.  Allergic Bronchopulmonary Aspergillosis masquerading as recurrent bacterial pneumonia.

Authors:  Vu Le Thuong; Lam Nguyen Ho; Ngoc Tran Van
Journal:  Med Mycol Case Rep       Date:  2016-06-27

Review 4.  Allergic Bronchopulmonary Aspergillosis.

Authors:  Michael C Tracy; Caroline U A Okorie; Elizabeth A Foley; Richard B Moss
Journal:  J Fungi (Basel)       Date:  2016-06-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.